These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 8709246)

  • 1. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.
    Beatty JA; Willett BJ; Gault EA; Jarrett O
    J Virol; 1996 Sep; 70(9):6199-206. PubMed ID: 8709246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
    Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroviral vector-transduced cells expressing the core polyprotein induce feline immunodeficiency virus-specific cytotoxic T-lymphocytes from infected cats.
    Li J; Brown WC; Song W; Carpino MR; Wolf AM; Grant CK; Elder JH; Collisson EW
    Virus Res; 1995 Oct; 38(2-3):93-109. PubMed ID: 8578869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
    Flynn JN; Keating P; Hosie MJ; Mackett M; Stephens EB; Beatty JA; Neil JC; Jarrett O
    J Immunol; 1996 Oct; 157(8):3658-65. PubMed ID: 8871667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.
    Flynn JN; Cannon CA; Beatty JA; Mackett M; Rigby MA; Neil JC; Jarrett C
    J Virol; 1994 Sep; 68(9):5835-44. PubMed ID: 8057464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
    Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
    Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein.
    Song W; Collisson EW; Li J; Wolf AM; Elder JH; Grant CK; Brown WC
    Virology; 1995 Jun; 209(2):390-9. PubMed ID: 7778274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.
    Toyosaki T; Miyazawa T; Furuya T; Tomonaga K; Shin YS; Okita M; Kawaguchi Y; Kai C; Mori S; Mikami T
    Arch Virol; 1993; 131(3-4):335-47. PubMed ID: 8102229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
    Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
    Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.
    Flynn JN; Cannon CA; Neil JC; Jarrett O
    J Virol; 1997 Oct; 71(10):7586-92. PubMed ID: 9311839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.
    Yang JS; English RV; Ritchey JW; Davidson MG; Wasmoen T; Levy JK; Gebhard DH; Tompkins MB; Tompkins WA
    J Virol; 1996 May; 70(5):3011-7. PubMed ID: 8627777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection.
    Burkhard MJ; Mathiason CK; Bowdre T; Hoover EA
    AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1767-78. PubMed ID: 11788028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats.
    Song W; Collisson EW; Billingsley PM; Brown WC
    J Virol; 1992 Sep; 66(9):5409-17. PubMed ID: 1323704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
    Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D
    Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gag- and env-specific serum antibodies in cats after natural and experimental infection with feline immunodeficiency virus.
    Rimmelzwaan GF; Siebelink KH; Broos H; Drost GA; Weijer K; van Herwijnen R; Osterhaus AD
    Vet Microbiol; 1994 Mar; 39(1-2):153-65. PubMed ID: 8203121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on feline CD8+ T cell non-cytolytic anti-feline immunodeficiency virus (FIV) activity.
    Hohdatsu T; Miyagawa N; Ohkubo M; Kida K; Koyama H
    Arch Virol; 2000; 145(12):2525-38. PubMed ID: 11205103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
    Dean GA; LaVoy A; Burkhard MJ
    Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
    Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
    AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Env and Gag protein expression patterns and epitope availability in feline immunodeficiency virus infected PBMC compared to infected and transfected feline model cell lines.
    Roukaerts IDM; Grant CK; Theuns S; Christiaens I; Acar DD; Van Bockstael S; Desmarets LMB; Nauwynck HJ
    Virus Res; 2017 Jan; 227():249-260. PubMed ID: 27836726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.